Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 6 minute read Pharma Industry News Zevra Therapeutics appoints new CFO. Is the rare disease biotech entering its next commercial cycle? Zevra Therapeutics appoints Justin Renz as CFO as the rare disease biotech prepares for commercialization expansion. Read what the leadership move signals. byPallavi MadhirajuMarch 5, 2026